2,3-DIHYDRO-1-(2,2,2-TRIFLUOROETHYL)-2-OXO-5-PHENYL -1H- 1,4-BENZODIAZEPINES AND METHOD OF PREVENTION OR TREATMENT OR ARYTHMIA Russian patent published in 2000 - IPC

Abstract RU 2149161 C1

FIELD: medicine. SUBSTANCE: described are new 2,3-dehydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepines of general formula I: wherein X and Y are independently hydrogen, chlorine or trifluoromethyl, and n is 0,1 or 2; R is hydrogen or fluorine; and their mixtures of enantiomers, individual diastereomers or individual enantiomers with all isomeric forms, and pharmaceutically acceptable salts, hydrates or crystalline forms thereof, which are antirythmic agents. Also described are methods of prevention of treatment of arythmia. EFFECT: improved properties of the title compounds. 5 cl, 19 ex, 1 tbl

Similar patents RU2149161C1

Title Year Author Number
DERIVATIVES OF DIAZEPINE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS WITH ARRYTHMIA 1994
  • Dzhon Dzh. Boldvin
  • Dehvid A. Klehrimon
  • Dzhejson M. Ehlliot
  • Nigel Liverton
  • Dehvid K. Remi
  • Garol'D G. Selnik
RU2155587C2
DERIVATIVES OF HEXAHYDRODIAZEPINONE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND USING IN PREPARING MEDICINAL AGENT FOR TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS 2003
  • Biftu Tesfaje
  • Ljang Guj-Baj
  • Tsjan' Sjaosja
  • Uehber Ehnn Eh.
  • Fehn Dantsin Dennis
RU2301803C2
SUBSTITUTED HETEROCYCLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION FOR BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS, METHOD OF BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS 1993
  • Konrad P.Dorn
  • Dzheffri Dzh.Khejl
  • Mal'Kol'M Mehkkoss
  • Sander Dzh.Millz
  • Tamara Lehdduvakhetti
  • Shrenik K.Shakh
RU2140914C1
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS 1995
  • Konrad P. Dorn
  • Dzheffri Dzh. Khejl
  • Mal'Kol'M Makkoss
  • Sander G. Mills
RU2170233C2
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE 1992
  • Glenn Dzh.Gomlej
  • Ehlizabet Stoner
RU2125879C1
NOVEL HETEROCYCLIC COMPOUNDS AND USE THEREOF IN MEDICINE AND COSMETICS 2015
  • Fournier Jean-Francois
  • Clary Laurence
  • Thoreau Etienne
RU2712971C2
CGRP RECEPTOR ANTAGONISTS 2004
  • Bergi Kristofer S.
  • Dehn Chzhehnu Tsz
  • Ngujen Dim N.
  • Pehuan Dehniel V.
  • Sho Ehntoni U.
  • Uill'Jams Tereza M.
RU2308458C2
1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORS 2005
  • Bilodo Mark T.
  • U. Chzhitsaj
  • Khartnett Dzhon
RU2344134C2
BENZOXAZINONES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF FOR INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, TREATMENT AND PROPHYLAXIS OF AIDS AND ARS, METHOD OF INHIBITION OF ACTIVITY OF HIV REVERSE TRANSCRIPTASE, METHOD OF PROPHYLAXIS OF HIV INFECTION, TREATMENT OF HIV AND ARS, COMBINATIONS, METHOD OF SYNTHESIS OF (-)-6-CHLORO- -4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4- -DIHYDRO-2H-3,1-BENZOXAZINE-2-ONE 1993
  • Jang Stiven D.
  • Britcher Sjuzn F.
  • Pejn Linda S.
  • Tran Likkhan O.
  • Lamma Vill'Jam K. Ml.
RU2186775C2
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS 2014
  • Chajlders Mettyu Llojd
  • Fuller Piter
  • Gerin Devid
  • Katts Dzhejson Devid
  • Pu Tsinlin
  • Skott Mark E.
  • Tompson Kristofer F.
  • Martines Mishel
  • Folkon Deniell
  • Torres Luis
  • Deng Jongki
  • Kurukulasuriya Ravi
  • Tszen Khunbo
  • Baj Yunfyn
  • Kun Norman
  • Lyu Yujmej
  • Chzhen Chzhisyan
RU2664533C2

RU 2 149 161 C1

Authors

Dehvid A.Klehremon

Najdzhel Liverton

Garol'D Dzh.Selnik

Dates

2000-05-20Published

1995-08-17Filed